These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35595342)

  • 41. Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States.
    Brandom BW; Larach MG; Chen MS; Young MC
    Anesth Analg; 2011 May; 112(5):1115-23. PubMed ID: 21372281
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Malignant Hyperthermia Susceptibility and Fitness for Duty.
    Lee MA; McGlinch EB; McGlinch MC; Capacchione JF
    Mil Med; 2017 Mar; 182(3):e1854-e1857. PubMed ID: 28290972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spinal cord injury-related thermoregulatory impairment masks a fatal malignant hyperthermia crisis: a case report.
    Andrade PV; Souza LS; Santos JM; Alves JFF; Lutke C; Amaral JLG; Vainzof M; Silva HCA
    Can J Anaesth; 2022 Mar; 69(3):369-373. PubMed ID: 34904211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Malignant hyperthermia: a potentially fatal complication of anesthesia.
    Stolworthy C; Haas RE
    Semin Perioper Nurs; 1998 Jan; 7(1):58-66. PubMed ID: 9510843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Malignant hyperthermia with excellent response to small dose of dantrolene.
    Chang KY; Ting CK; Chan KH; Tsai SK
    Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):241-5. PubMed ID: 15679136
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: method to obtain prophylaxis and therapeusis.
    Flewellen EH; Nelson TE
    Anesthesiology; 1980 Apr; 52(4):303-8. PubMed ID: 7362049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Malignant hyperthermia in a patient with Graves' disease during subtotal thyroidectomy.
    Nishiyama K; Kitahara A; Natsume H; Matsushita A; Nakano K; Sasaki S; Genma R; Yamamoto Y; Nakamura H
    Endocr J; 2001 Apr; 48(2):227-32. PubMed ID: 11456272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MALIGNANT HYPERTHERMIA IN A CHILD AFTER MAGNETIC RESONANCE IMAGING: A CASE REPORT.
    Almeida CG; Colleti Junior J
    Rev Paul Pediatr; 2020; 38():e2018267. PubMed ID: 32074225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Case of malignant hyperthermia in which treatment was carried out smoothly].
    Morota T; Endo K; Furuta S; Obara S; Ohmuzo H; Kaneko T; Onuma T; Watanabe K
    Masui; 2007 Jul; 56(7):826-30. PubMed ID: 17633846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dantrolene sodium is able to reduce the resting ionic [Ca2+]i in muscle from humans with malignant hyperthermia.
    López JR; Medina P; Alamo L
    Muscle Nerve; 1987 Jan; 10(1):77-9. PubMed ID: 3561441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Age-Specific Clinical Features of Pediatric Malignant Hyperthermia: A Review of 187 Cases Over 60 Years in Japan.
    Otsuki S; Miyoshi H; Mukaida K; Yasuda T; Nakamura R; Tsutsumi YM
    Anesth Analg; 2022 Jul; 135(1):128-135. PubMed ID: 34962895
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Case Report of the Use of an Intravascular Cooling Device in the Management of Malignant Hyperthermia.
    Von Schweinitz B; Gros BJ
    Ther Hypothermia Temp Manag; 2024 Jun; 14(2):125-127. PubMed ID: 38808487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Verapamil is not a therapeutic adjunct to dantrolene in porcine malignant hyperthermia.
    Gallant EM; Foldes FF; Rempel WE; Gronert GA
    Anesth Analg; 1985 Jun; 64(6):601-6. PubMed ID: 4003778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.
    Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB
    Anesth Analg; 2014 Dec; 119(6):1359-66. PubMed ID: 25268394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Malignant hyperthermia in a 6-month-old infant.
    Mathur PR; Rundla M; Jain N; Mathur V
    Saudi J Anaesth; 2016; 10(3):353-5. PubMed ID: 27375398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Registration of peranesthetic cases of malignant hyperthermia in France. An update].
    Jacquot C; Stieglitz P; Kozak-Reiss G; Krivosic-Horber R; Laxenaire MC; Lienhart A; Nivoche Y
    Ann Fr Anesth Reanim; 1988; 7(6):524-34. PubMed ID: 3223647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Malignant Hyperthermia.
    Kaur H; Katyal N; Yelam A; Kumar K; Srivastava H; Govindarajan R
    Mo Med; 2019; 116(2):154-159. PubMed ID: 31040503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fulminant-type malignant hyperthermia in Japan: cumulative analysis of 383 cases.
    Migita T; Mukaida K; Kawamoto M; Kobayashi M; Yuge O
    J Anesth; 2007; 21(2):285-8. PubMed ID: 17458663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Malignant hyperthermia during pediatric kidney transplantation-A medical and ethical quandary.
    Srinivasan SP; Eldo N; Nair SG
    Pediatr Transplant; 2021 May; 25(3):e13923. PubMed ID: 33314641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Magnesium does not influence the clinical course of succinylcholine-induced malignant hyperthermia.
    Metterlein T; Schuster F; Kranke P; Hager M; Roewer N; Anetseder M
    Anesth Analg; 2011 May; 112(5):1174-8. PubMed ID: 21474662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.